Delhi thalassemia patients face a dire shortage of the essential injection Desferal, causing panic and desperation as ...

The cumulative results of decades of work and advances in medicine are reflected in the increased survival of thalassaemia ...

The fall in AGIO stock comes after reports of an unexpected side effect linked to its sole-marketed drug Pyrukynd in thalassemia patients.

Emma Reeve, the chair of Editas’ board, is also resigning, to be replaced by Jessica Hopfield, Ph.D., the company explained ...

How cruise line tips get shared and who you should tip is something that many passengers have questions about.

When you give to Light Up A Lawn, Light Up A Life, you are supporting programs like Nationwide Children's cutting-edge gene ...

The biotech will cut 180 positions, or about two-thirds of its workforce, and discontinue development of its lead drug ...

ENERGIZE-T Study Achieved Primary and All Key Secondary Endpoints in Adult Patients with Transfusion-Dependent Alpha- or Beta-Thalassemia –– ...

Shares of Agios Pharmaceuticals collapsed Monday on an unexpected side effect related to the company's thalassemia treatment, ...

Editas Medicine ( (EDIT) ) just unveiled an announcement.

Sri Lanka has yet to conduct the necessary tests prescribed by the World Health Organization (WHO) to ensure food quality, ...

Investing in biotech stocks isn't for everyone because the very nature of their business is fraught with risk. As a result, ...